Exact Sciences
JP Morgan Healthcare Conference Day 3: Quest Diagnostics, Exact Sciences, Quidel, More
Highlights of the third day included Quest's view on its information and services business and Quidel's take on the proposed Ortho Clinical buy.
Exact Sciences Projects up to $475M in Q4 Revenues, Acquires Testing Lab, Inks Licensing Deal
The approximately 2 percent increase over Q4 2020 results beat analysts' expectations, and the acquisition news heralds market expansion into hereditary cancer testing.
Exact Sciences, Pfizer End Cologuard Copromotion Agreement
In September, Exact hired 400 former Pfizer sales reps who were displaced from their jobs in late August and who had been promoting Cologuard.
Exact Sciences, Jefferson Health to Study Blood-Based Multicancer Early Detection Test
The partners will survey doctors, care coordinators, and patients on metrics like test safety and efficacy, and how to best implement multicancer testing.
After fighting through some headwinds in 2021, the company said it will show off new data and tests in the next couple of years.
Nov 2, 2021
Exact Sciences Q3 Revenues Rise 12 Percent
Jul 28, 2021
Exact Sciences Q2 Revenues Rise 62 Percent
Jul 14, 2021
May 5, 2021
Jan 11, 2021